VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
37 hedge funds and large institutions have $305M invested in Verona Pharma in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.32% less ownership
Funds ownership: 8.62% → 8.3% (-0.32%)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $100K
Holders
37
Holding in Top 10
4
Calls
–
Puts
$100K
Top Buyers
| 1 | +$21.3M | |
| 2 | +$9.29M | |
| 3 | +$1.08M | |
| 4 |
QSS
Quantitative Systematic Strategies
Ponte Vedra Beach,
Florida
|
+$244K |
| 5 |
FA
Forefront Analytics
West Conshohocken,
Pennsylvania
|
+$118K |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$5.22M | |
| 3 | -$1.94M | |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.25M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.19M |